Evolent Health, Inc. (EVH)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Evolent Health, Inc. (EVH) is down 5.5% since the beginning of the year. At $4 per share, EVH is trading 68.7% below its 52-week high of $12. Investors who bought $1,000 worth of EVH shares 5 years ago would now be looking at an investment worth $205.

Evolent Health, Inc. (EVH) has returned -5.50% so far this year and -55.79% over the past 12 months. Over the last ten years, EVH has returned -13.11% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Jun 5, 2015, EVH's average daily return is +0.02%, while the average monthly return is +0.53%. At this rate, an investment would double in approximately 10.9 years.

Historically, 51% of months were positive and 49% were negative. The best month was Apr 2026 with a return of +64.5%, while the worst month was Nov 2024 at -44.7%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 7 months.

On a daily basis, EVH closed higher 50% of trading days. The best single day was Mar 26, 2020 with a return of +31.3%, while the worst single day was Nov 8, 2024 at -45.6%.

Evolent Health, Inc. has an annualized alpha of -10.41%, beta of 1.24, and R2 of 0.13 versus S&P 500 Index. Calculated based on daily prices since June 08, 2015.

• This stock participated in 162.85% of S&P 500 Index downside but only 53.77% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.13 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

EVH ranks 14 for risk / return — in the bottom 14% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Evolent Health, Inc. (EVH) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Evolent Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Evolent Health, Inc. was 94.54%, occurring on Mar 30, 2026. The portfolio has not yet recovered.

The current Evolent Health, Inc. drawdown is 90.49%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Evolent Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Evolent Health, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.